genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2012
Thrombocytopenia
Industry News
Shire to Buy FerroKin for $100M Cash to Acquire Phase II Iron Chelator
Drug Discovery
G-Zero Awarded $3.6M to Advance Pharmacoquiescence Approach to Radiomitigation
News
Chinese Regulator Grants Label Extension for 3SBio’s TPIAO as Treatment for ITP
Drug Discovery
aTyr Pockets $23M to Advance Preclinical Physiocrine-Based Candidates
News
ThromboGenics’ Microplasmin Succeeds in Second Late-Stage VMA Study
News
GSK Wins EC Clearance for Drug to Treat Idiopathic Thrombocytopenic Purpura
News
GSK Gains Rights to Ligand’s Thrombopoietin Program with an Initial Payment of $5M
News
FDA Approval of GSK’s Promacta Triggers $2M Payment to Ligand
News
MGI Obtains Rights to Thrombocytopenia Treatment for $45M
1
2
Page 2 of 2
Scroll Up
Scroll Up
